gallopamil has been researched along with esmolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minge, C; Mitrovic, V; Oehm, E; Schlepper, M; Thürmann, P | 1 |
| Haberbosch, W; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
3 trial(s) available for gallopamil and esmolol
| Article | Year |
|---|---|
[Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Atrial Natriuretic Factor; Coronary Angiography; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Gallopamil; Hemodynamics; Humans; Infusions, Intravenous; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Propanolamines; Renin; Single-Blind Method | 1994 |
Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Catecholamines; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Gallopamil; Hemodynamics; Humans; Lactic Acid; Male; Middle Aged; Potassium Channel Blockers; Propanolamines; Treatment Outcome | 1998 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dihydropyridines; Electrocardiography; Exercise Test; Gallopamil; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channel Blockers; Potassium Channels; Propanolamines; Time Factors; Vasodilator Agents | 2000 |